Syneos Health, Inc. (SYNH) Tops Q1 EPS by 4c, Beats on Revenues; Boosts FY18 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Syneos Health, Inc. (SYNH) Announces Promotion of Jason Meggs to CFO Position
May 9, 2018 6:21 AM EDTSyneos Health (NASDAQ: SYNH) today announced that Jason Meggs has been promoted to the position of Chief Financial Officer of the Company, effective May 6. Meggs has served as interim CFO of Syneos Health since February 2018.
With two decades of financial experience across both public and private markets, and a deep understanding of the biopharma industry and... More
